AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) announced that it will release unaudited financial results for the quarter and fiscal year ended September 30, 2009 before market open on Tuesday, November 24, 2009. Keith Katkin, President and Chief Executive Officer, Randall Kaye, M.D., Senior Vice President and Chief Medical Officer, and Christine Ocampo, Vice President, Finance, will host an investment community conference call that same day at 8:00 a.m. Pacific time / 11:00 a.m. Eastern time to discuss those results and answer questions.
Currently viewing and reading
Related Post
- Javelin Pharmaceuticals Reports Fiscal Results for the Year Ended 2009 (March 10th, 2010)
- Intuitive Surgical, Inc. Announces First Quarter, 2010 Earnings Conference Call (March 10th, 2010)
- ExonHit Therapeutics Reports 2009 Annual Results (March 10th, 2010)
- Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2009 Financial Results (March 10th, 2010)
- BioMimetic Therapeutics to Report 2009 Fourth Quarter and Year-End Financial Results on March 11 (March 9th, 2010)
No Comment Received
Leave A Reply